-
2025-520896-13-00
5
2025-12-04
Friedreich’s ataxia
-
2025-521382-27-00
10
2025-12-04
Moderately to Severely Active Crohn's Disease
-
2025-521381-10-00
5
2025-12-03
Moderately to Severely Active Ulcerative Colitis
-
2024-512577-27-00
5
2025-12-02
Chronic kidney disease in paediatric patients
-
2025-521242-26-00
4
2025-11-27
Moderately to Severely Active Ulcerative Colitis
-
2025-520927-26-00
5
2025-11-24
Metastatic Castration-resistant Prostate Cancer (mCRPC)
-
2024-517553-26-00
5
2025-11-12
Advanced ALK-positive non-small cell lung cancer (NSCLC)
-
2025-521260-35-00
6
2025-11-07
acute ischemic stroke and atrial fibrillation (AF)
-
2024-514693-47-01
11
2025-10-28
EGFR mutated locally advanced or metastatic non-small cell lung cancer
-
2024-517121-10-00
5
2025-10-17
Menstrual Migraine
-
2025-521188-11-00
5
2025-10-15
Type 2 diabetes
-
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig
-
2024-517671-21-00
5
2025-09-30
Coronavirus Disease 2019 (COVID-19)
-
2024-517232-22-00
5
2025-09-26
KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorect
-
2024-514181-39-00
5
2025-09-23
Metastatic renal cell carcinoma
-
2024-520210-21-00
5
2025-09-19
Crohn’s Disease
-
2024-518810-23-00
6
2025-09-17
Failure to wean from invasive ventilation.
-
2024-517051-12-00
4
2025-09-16
Relapsed primary large B-cel lymphoma of the central nervous system
-
2025-520757-36-00
6
2025-09-15
Rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis
-
2025-521158-40-00
4
2025-09-12
oesophageal cancer
-
2025-520483-17-01
6
2025-09-02
Systemic sclerosis
-
2024-518276-32-00
4
2025-08-29
Locally advanced and unresectable Stage III non-small cell lung cancer
-
2024-518154-16-00
5
2025-08-27
non-small cell lung cancer
-
2023-510382-10-00
5
2025-08-25
HELLP syndrome